A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Zeidner, Joshua F, Lin, Tara L, Vigil, Carlos E, Fine, Gil, Yair Levy, M, Nazha, Aziz, Esteve, Jordi, Lee, Daniel J, Yee, Karen, Dalovisio, Andrew, Wang, Eunice S, Bergua Burgues, Juan M, Schriber, Jeffrey, Litzow, Mark R, Frankfurt, Olga, Castillo, Teresa Bernal Del, Bhatt, Vijaya Raj, Bhatnagar, Bhavana, Mehta, Priyanka, Dillon, Richard, Vicente, Maria Vidriales, Anthony, Stephen, Bearss, David, Montesinos, Pau, Douglas Smith, B
Published in Blood cancer journal (New York) (30.10.2021)
Published in Blood cancer journal (New York) (30.10.2021)
Get full text
Journal Article
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial
Bahlis, Nizar J, Costello, Caitlin L, Raje, Noopur S, Levy, Moshe Y, Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael H, Damore, Michael A, Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M, Trudel, Suzanne, Jakubowiak, Andrzej, Gasparetto, Cristina, Chu, Michael P, Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M
Published in Nature medicine (01.10.2023)
Published in Nature medicine (01.10.2023)
Get full text
Journal Article
A Single Institution Experience of Treating Patients with High Dose Methotrexate for Primary CNS Lymphoma and with Secondary CNS Involvement
Lalani, Tanya L, Staton, Ashley D., Dalovisio, Andrew P., Finn, Laura E., Badari, Ambuga, Davis, Carter Thomas
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Jimenez, Antonio M., MD, Moreno, Alfonso D, Maciejewski, John, MD, PhD, Dalovisio, Andrew, MD, Katz, Deborah, MD, Havey, Christina, Merchant, Nazneen, MBBS, Fung, Henry C., MD, Nathan, Sunita, MD
Published in Biology of blood and marrow transplantation (01.02.2015)
Published in Biology of blood and marrow transplantation (01.02.2015)
Get full text
Journal Article
Molecular features and outcomes for patients receiving elranatamab for relapsed or refractory multiple myeloma in MagnetisMM-1
Tomasson, Michael H., Bahlis, Nizar J., Costello, Caitlin, Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai R., Solh, Melhem M., Damore, Michael A., Jiang, Sibo, Xie, Tao, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Jakubowiak, Andrzej J., Gasparetto, Cristina, Chu, Michael, Dalovisio, Andrew Peter, Sebag, Michael, Lesokhin, Alexander M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Elranatamab, a BCMA Targeted T-Cell Engaging Bispecific Antibody, Induces Durable Clinical and Molecular Responses for Patients with Relapsed or Refractory Multiple Myeloma
Raje, Noopur, Bahlis, Nizar Jacques, Costello, Caitlin, Dholaria, Bhagirathbhai, Solh, Melhem, Levy, Moshe Yair, Tomasson, Michael H, Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael P, Gasparetto, Cristina J., Dalovisio, Andrew P., Sebag, Michael, Lesokhin, Alexander M
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Elranatamab, a BCMA-targeted T-cell redirecting immunotherapy, for patients with relapsed or refractory multiple myeloma: Updated results from MagnetisMM-1
Jakubowiak, Andrzej J., Bahlis, Nizar J., Raje, Noopur S., Costello, Caitlin, Dholaria, Bhagirathbhai R., Solh, Melhem M., Levy, Moshe Y., Tomasson, Michael H, Dube, Harman, Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Chu, Michael P, Gasparetto, Cristina J., Dalovisio, Andrew Peter, Sebag, Michael, Lesokhin, Alexander M.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Acute Myeloid Leukemia (AML): Results of Newly Diagnosed High-Risk Exploratory Arm
Zeidner, Joshua F., Lee, Daniel J., Fine, Gil, Wang, Eunice S., Bhatt, Vijaya R., Dalovisio, Andrew, Montesinos, Pau, Kolibaba, Kathryn S., Anthony, Stephen P., Bearss, David J., Smith, B. Douglas
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) Targeted CD3-Engaging Bispecific Molecule, for Patients with Relapsed or Refractory Multiple Myeloma: Results from Magnetismm-1
Sebag, Michael, Raje, Noopur S., Bahlis, Nizar J., Costello, Caitlin, Dholaria, Bhagirathbhai, Solh, Melhem, Levy, Moshe Y., Tomasson, Michael H., Dube, Harman, Damore, Michael A., Lon, Hoi Ken, Basu, Cynthia, Skoura, Athanasia, Chan, Edward, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael P., Gasparetto, Cristina, Dalovisio, Andrew P., Lesokhin, Alexander
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Midostaurin in Adults with Newly Diagnosed FLT3-Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Program
Perl, Alexander E., Sweet, Kendra L., Roboz, Gail J., Strickland, Stephen A., Litzow, Mark R., Bonifacio, Gaetano J, Haines, Kelly, Barbera, Alysha, Purkayastha, Das, Dalovisio, Andrew
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM)
Bahlis, Nizar J., Raje, Noopur S., Costello, Caitlin, Dholaria, Bhagirathbhai R., Solh, Melhem M., Levy, Moshe Y., Tomasson, Michael H, Dube, Harman, Liu, Feng, Liao, Kai Hsin, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Jakubowiak, Andrzej J., Chu, Michael P, Gasparetto, Cristina, Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Preliminary Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Subcutaneously (SC) Administered PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Lesokhin, Alexander M., Levy, Moshe Y., Dalovisio, Andrew P., Bahlis, Nizar J., Solh, Melhem, Sebag, Michael, Jakubowiak, Andrzej, Jethava, Yogesh S., Costello, Caitlin L., Chu, Michael P., Savona, Michael R., Gasparetto, Cristina, Trudel, Suzanne, Chou, Jeffrey, Udata, Chandrasekhar, Basu, Cynthia, Krupka, Heike I., Raje, Noopur S.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Radius-X: An Expanded Treatment Protocol of Midostaurin in Adults with Newly Diagnosed FLT3-Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy
Roboz, Gail J., Strickland, Stephen A., Litzow, Mark R., Dalovisio, Andrew, Perl, Alexander E., Bonifacio, Gaetano, Haines, Kelly, Barbera, Alysha, Purkayastha, Das, Sweet, Kendra
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Updated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation-positive acute myeloid leukemia: the RADIUS-X expanded access program
Roboz, Gail J., Strickland, Stephen A., Litzow, Mark R., Dalovisio, Andrew, Perl, Alexander E., Bonifacio, Gaetano, Haines, Kelly, Barbera, Alysha, Purkayastha, Das, Sweet, Kendra
Published in Leukemia & lymphoma (01.12.2020)
Published in Leukemia & lymphoma (01.12.2020)
Get full text
Journal Article
Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)
Zeidner, Joshua F, Lin, Tara L, Vigil, Carlos E, Dalovisio, Andrew, Wang, Eunice S., Levy, Moshe Yair, Frattini, Mark G., Lee, Daniel J., Montesinos, Pau, Bergua Burgues, Juan Miguel Miguel, Schriber, Jeffrey R., Anthony, Stephen, Bearss, David J., Smith, B. Douglas
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM)
Dholaria, Bhagirathbhai, Bahlis, Nizar, Raje, Noopur, Costello, Caitlin, Solh, Melhem, Levy, Moshe, Tomasson, Michael, Dube, Harman, Damore, Michael, Lon, Hoi Kei, Basu, Cynthia, Skoura, Athanasia, Chan, Edward, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael, Gasparetto, Cristina, Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Get full text
Journal Article
MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM)
Levy, Moshe, Bahlis, Nizar, Raje, Noopur, Costello, Caitlin, Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael, Dube, Harman, Damore, Michael, Lon, Hoi Kei, Basu, Cynthia, Skoura, Athanasia, Chan, Edward, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael, Gasparetto, Cristina, Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM)
Levy, Moshe, Bahlis, Nizar, Raje, Noopur, Costello, Caitlin, Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael, Dube, Harman, Damore, Michael, Lon, Hoi Kei, Basu, Cynthia, Skoura, Athanasia, Chan, Edward, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael, Gasparetto, Cristina, Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
RADIUS-X: An Expanded Treatment Protocol for Midostaurin in Combination with Standard Chemotherapy in Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
Roboz, Gail, Strickland, Stephen, Litzow, Mark, Dalovisio, Andrew, Perl, Alexander, Bonifacio, Gaetano, Haines, Kelly, Barbera, Alysha, Purkayastha, Das, Sweet, Kendra
Published in Clinical lymphoma, myeloma and leukemia (01.09.2018)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2018)
Get full text
Journal Article